
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Land Rover Just Unveiled Its Dakar Rally Defender - 2
A Manual for Extravagant Vehicles Available in 2024 - 3
Carina Nebula shines with white-blue stars | Space photo of the day for Jan. 5, 2026 - 4
2024 Eurovision winner Nemo returns trophy over Israel's participation - 5
The Electric Bicycle Americans Can Confide in 2024
2025 Yachting Editors' Choice Awards: Yachts
The moon and sun figure big in the new year's lineup of cosmic wonders
'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
Amateur's Manual for Venture Strategies for Tenderfoots
ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
An Extended period of Voyaging Carefully: the World with Reason
Pain at the pump for Hampton Roads residents
Partake in the Outside: Senior-Accommodating Exercises for 2024
They want better health care — so they're turning to crypto startups












